Peer Exchange

Role of Health Plans in Medicaid Expansion
July 31, 2017 – 
Panelists Joseph Alvarnas, MD; John Fox, MD; Elizabeth Carpenter; and Robert Carlson, MD, discuss the political aspects of health coverage and the importance of patient access to healthcare.
Barriers to Traditional Insulin Therapy
July 28, 2017 – 
Louis S. Christos, RPh, reviews some of the barriers to traditional insulin therapy for patients with diabetes.
Formulary Management: Antidiabetes Medications
July 28, 2017 – 
Louis S. Christos, RPh, provides insight on the evaluation of antidiabetes drugs for formulary inclusion and discusses management trends and the importance of individualized care.
ACA, Medicaid Expansion, and Cancer Care
July 24, 2017 – 
Leonard Lichtenfeld, MD, provides insight into the importance of patient access to oncology care.
ACA: Effect on Patients With Chronic Conditions
July 24, 2017 – 
Panelists Joseph Alvarnas, MD; Elizabeth Carpenter; and John Fox, MD, provide insight into the impact of the Affordable Care Act on patients with chronic disease.
Influence of Value Frameworks in Clinical Practice
July 19, 2017 – 
Panelists Joseph Alvarnas, MD; Robert Carlson, MD; and John Fox, MD, discuss the influence of various value frameworks in oncology care.
Using Reimbursement Models to Overcome Oncology Care Gaps
July 19, 2017 – 
Panelists Joseph Alvarnas, MD, and Bhuvana Sagar, MD share their experience with and thoughts on overcoming oncology care gaps, potentially with reimbursement models.
Payer Policy and Provider Choice in Wet AMD
July 13, 2017 – 
Panelists Peter L. Salgo, MD; Charles Wykoff, MD, PhD; Jared Nielsen, MD; Gary L. Johnson, MD, MS, MBA; and Peter Dehnel, MD, discuss the importance of payer and provider collaboration on ensuring appropriate access to therapies for wet age-related macular degeneration.
Patient Cost Considerations in Wet AMD Management
July 13, 2017 – 
Panelists Peter L. Salgo, MD; Peter Dehnel, MD; Gary L. Johnson, MD, MS, MBA; Charles Wykoff, MD, PhD; and Jared Nielsen, MD, share their thoughts regarding the impact of wet age-related macular degeneration medication cost on patients.
Developing Appropriate Quality Measures in Oncology
July 10, 2017 – 
Leonard Lichtenfeld, MD, outlines the detailed process by which quality measures are instated in oncology care.
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!